Watchlist Price Alert

Nektar Therapeutics (NKTR)

NASDAQ: NKTR · Real-Time Price · USD

8.56

-0.20 (-2.28%)

At close: Jun 13, 2025, 3:59 PM

8.70

1.58%

After-hours: Jun 13, 2025, 07:18 PM EDT

Nektar Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	98.43M	90.12M	92.06M	101.91M	152.91M	114.62M	1.19B	307.71M	165.44M
Cost of Revenue	30.69M	33.77M	21.64M	24.9M	19.48M	21.37M	24.41M	30.55M	30.21M
Gross Profit	67.74M	56.35M	70.42M	77.01M	133.44M	93.24M	1.17B	277.16M	135.22M
Operating Income	-105.2M	-263.68M	-240.24M	-446.1M	-379.92M	-440.04M	687.93M	-59.64M	-112.86M
Interest Income	14.5M	19.01M	6.67M	2.57M	18.28M	46.34M	37.57M	4.52M	2.39M
Pretax Income	-119.2M	-276.26M	-364.98M	-523.28M	-443.95M	-440.05M	682.73M	-96.08M	-152.65M
Net Income	-118.96M	-276.06M	-368.2M	-523.84M	-444.44M	-440.67M	681.31M	-96.69M	-153.52M
Selling & General & Admin	76.75M	77.42M	92.33M	122.84M	104.68M	98.71M	81.44M	52.36M	44.27M
Research & Development	120.91M	114.16M	218.32M	400.27M	408.68M	434.57M	399.54M	268.46M	203.8M
Other Expenses	-24.72M	n/a	-116K	-24.41M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	172.94M	190.9M	310.66M	523.11M	513.36M	533.28M	480.98M	320.82M	248.08M
Interest Expense	28.11M	25.33M	28.91M	47.31M	37.12M	46.35M	42.78M	40.95M	42.18M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	203.63M	227.55M	332.29M	548.01M	532.84M	554.65M	505.39M	351.37M	278.29M
Income Tax Expense	-239K	-200K	3.21M	557K	493K	613K	1.41M	616K	876K
Shares Outstanding (Basic)	205.66M	190M	187.14M	183.3M	178.58M	174.99M	180.12M	155.95M	139.57M
Shares Outstanding (Diluted)	205.66M	190M	187.14M	183.3M	178.58M	174.99M	180.12M	155.95M	139.6M
EPS (Basic)	-0.58	-1.45	-1.97	-2.86	-2.49	-2.52	3.78	-0.62	-1.1
EPS (Diluted)	-0.58	-1.45	-1.97	-2.86	-2.49	-2.52	3.78	-0.62	-1.1
EBITDA	-86.7M	-243.11M	-323.87M	-462.97M	-394.33M	-382.7M	734.3M	-42.52M	-97.27M
EBIT	-91.09M	-250.92M	-336.07M	-475.97M	-406.83M	-393.7M	725.5M	-55.12M	-110.47M
Depreciation & Amortization	4.39M	7.82M	12.2M	13M	12.5M	11M	8.8M	12.6M	13.2M